High-intensity Interval Training: Modulating Interval Duration in Overweight/obese Men
Overview
Affiliations
Introduction: High-intensity interval training (HIIT) is a time-efficient strategy shown to induce various cardiovascular and metabolic adaptations. Little is known about the optimal tolerable combination of intensity and volume necessary for adaptations, especially in clinical populations.
Objectives: In a randomized controlled pilot design, we evaluated the effects of two types of interval training protocols, varying in intensity and interval duration, on clinical outcomes in overweight/obese men.
Methods: Twenty-five men [body mass index (BMI) > 25 kg · m(2)] completed baseline body composition measures: fat mass (FM), lean mass (LM) and percent body fat (%BF) and fasting blood glucose, lipids and insulin (IN). A graded exercise cycling test was completed for peak oxygen consumption (VO2peak) and power output (PO). Participants were randomly assigned to high-intensity short interval (1MIN-HIIT), high-intensity interval (2MIN-HIIT) or control groups. 1MIN-HIIT and 2MIN-HIIT completed 3 weeks of cycling interval training, 3 days/week, consisting of either 10 × 1 min bouts at 90% PO with 1 min rests (1MIN-HIIT) or 5 × 2 min bouts with 1 min rests at undulating intensities (80%-100%) (2MIN-HIIT).
Results: There were no significant training effects on FM (Δ1.06 ± 1.25 kg) or %BF (Δ1.13% ± 1.88%), compared to CON. Increases in LM were not significant but increased by 1.7 kg and 2.1 kg for 1MIN and 2MIN-HIIT groups, respectively. Increases in VO2peak were also not significant for 1MIN (3.4 ml·kg(-1) · min(-1)) or 2MIN groups (2.7 ml · kg(-1) · min(-1)). IN sensitivity (HOMA-IR) improved for both training groups (Δ-2.78 ± 3.48 units; p < 0.05) compared to CON.
Conclusion: HIIT may be an effective short-term strategy to improve cardiorespiratory fitness and IN sensitivity in overweight males.
Pourmotahari A, Shahrbanian S, Supriya R, Saeidi A Medicina (Kaunas). 2025; 61(2).
PMID: 40005372 PMC: 11857264. DOI: 10.3390/medicina61020255.
Non-Pharmacological Pain Management for Osteoarthritis: Review Update.
Allen K, Ambrose K, Booker S, Buck A, Huffman K Curr Rheumatol Rep. 2025; 27(1):19.
PMID: 39969767 DOI: 10.1007/s11926-025-01185-w.
Lu Y, Baker J, Ying S, Lu Y Front Endocrinol (Lausanne). 2025; 16:1481200.
PMID: 39917538 PMC: 11798773. DOI: 10.3389/fendo.2025.1481200.
Liao T, Zheng C, Xue J, Wang Y Front Endocrinol (Lausanne). 2024; 15:1381925.
PMID: 39398340 PMC: 11466748. DOI: 10.3389/fendo.2024.1381925.
Morcillo-Losa J, Diaz-Martinez M, Ceylan H, Moreno-Vecino B, Bragazzi N, Parraga Montilla J J Clin Med. 2024; 13(5).
PMID: 38592165 PMC: 10931549. DOI: 10.3390/jcm13051299.